MarketLine - Sinclair Pharma (SPH) Sinclair Pharma plc â€“ Mergers Acquisitions (MA), Partnerships Alliances and Investment Report

Report

MarketLine

MarketLine Department

EUR 311.72 For Business Accounts Only

Sinclair Pharma plc â€“ Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Summary
Pharmaceuticals and Healthcare

Key Findings
Pharmaceuticals and Healthcare

Pharmaceuticals and Healthcare

Reasons To Buys
MarketLine

Key Highlights
United Kingdom

14/06/2017 110 EN

Underlying

Sinclair Pharma

Sinclair Pharma is a pharmaceutical company. Co. manufactures, commercializes and sales aesthetic products with a portfolio based on improving facial shape and volumisation. Co.'s aesthetics portfolio comprised of: Silhouette Soft®, which provides face and neck reshaping by lifting cheeks, eyebrows, jawline, and neck tissues, stimulating the production of natural collagen and enhancing skin quality; EllansA(c)®, which regenerates the volume and restores the shape; Perfectha®, a biphasic Hyaluronic acid filler range for volume and contouring, designed for wrinkle correction, facial contouring and volume restoration, combining ease of injection; and Sculptra®/New-Fill®, a collagen stimulator.

See profile

GB0033856740 United Kingdom

Provider

MarketLine

MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.

For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.

MarketLine’ holistic business intelligence report collection includes:

Industry Intelligence

‒ Industry Profiles

‒ Market Forecasts

‒ Porter’s Five Forces Analysis

Company Intelligence

‒ Company Profiles

‒ SWOT Analysis

‒ Financial Deals

Country and City Intelligence

‒ Country and City Profiles

‒ PEST/PESTLE Analysis

‒ Socio and macro-economic indicators

See profile

Analysts

MarketLine Department

Other Reports on these Companies

Independent Investment Research

Monthly LMI Update Independent Investment Research

Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked. This compares to the total dividends of 5 cents per share in FY20. The Board has confirmed that, in...

August 6, 2021 August 6, 2021 10 EN

Fundamental Research

Feasibility Study Results in December to be a Catalyst for this Junior

EUR 18.29

November 25, 2019 November 25, 2019 14 EN

SmartInsider

A director bought 200,000 shares at 23p and

A director at Sinclair IS Pharma bought 200,000 shares at 23p and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names o...

Free Trial

January 17, 2018 January 17, 2018 1 EN

Brazil In-depth PESTLE Insights

Brazil In-depth PESTLE Insights Summary This PESTLE country analysis report on Brazil provides a holistic view of the country, with insightful analysis of current and future issues, supplemented with relevant quantitative data to support trend analysis. Synopsis - Understand the political system in Brazil through analysis of key figures in the country and governance indicators. - Understand the economic situation in Brazil through a balanced assessment of core macroeconomic issues. - Understand customer demographics in Brazil through analysis of income distribution and the rural-urban spli...

EUR 320.04

September 6, 2024 September 6, 2024 1 EN

MarketLine Department

MarketLine Department

Hong Kong In-depth PESTLE Insights

Hong Kong In-depth PESTLE Insights Summary This PESTLE country analysis report on Hong Kong provides a holistic view of the country, with insightful analysis of current and future issues, supplemented with relevant quantitative data to support trend analysis. Synopsis - Understand the political system in Hong Kong through analysis of key figures in the country and governance indicators. - Understand the economic situation in Hong Kong through a balanced assessment of core macroeconomic issues. - Understand customer demographics in Hong Kong through analysis of income distribution and the r...

EUR 320.04

September 4, 2024 September 4, 2024 1 EN

MarketLine Department

MarketLine Department

OMV AG - Mergers & Acquisitions (M&A), Partnerships & Alliances

Summary Marketline's OMV AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by OMV AG - Mergers & Acquisitions (M&A), Partnerships & Alliances since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sus...

EUR 320.04

August 29, 2024 August 29, 2024 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Sinclair Pharma plc â€“ Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Monthly LMI Update Independent Investment Research

Feasibility Study Results in December to be a Catalyst for this Junior

A director bought 200,000 shares at 23p and

Brazil In-depth PESTLE Insights

Hong Kong In-depth PESTLE Insights

OMV AG - Mergers & Acquisitions (M&A), Partnerships & Alliances

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe